title: Association of tamoxifen with meningioma: a population-based study in Sweden.
abstract: Previous studies suggest that hormone therapy may play an important role in the development of meningioma. However, it is unclear whether medication with tamoxifen can prevent meningioma. Our study cohort included all women who were diagnosed with breast cancer between 1961 and 2010, and a total of 227 535 women were identified with breast cancer with a median age at diagnosis of 63 years. Women diagnosed with breast cancer after 1987 were defined as tamoxifen exposed; those diagnosed with breast cancer before or during 1987 were defined as not exposed to tamoxifen. Standardized incidence ratios (SIRs) were used to calculate the risk of subsequent meningioma. Of these women, 223 developed meningioma. For women without tamoxifen exposure, the risk of meningioma was significantly increased, with an SIR of 1.54 (95% confidence interval 1.30-1.81); the risk was not increased in those with tamoxifen exposure (SIR=1.06, 95% confidence interval 0.84-1.32). The increased risk of meningioma in women without tamoxifen exposure persisted during 10 years of follow-up. In this historical cohort study, we found that women diagnosed with breast cancer but not treated with tamoxifen had an increased incidence of meningioma, whereas the incidence was close to that of the general population in patients treated with tamoxifen. This suggests that tamoxifen may prevent the development of meningioma.
authors: aCenter for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden bStanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
authors: Jianguang
authors: J
authors: Ji
authors: Jan
authors: J
authors: Sundquist
authors: Kristina
authors: K
authors: Sundquist
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008577:Meningeal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D008579:Meningioma / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D018570:Risk Assessment; D013548:Sweden / Q000453:epidemiology; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen
references: J Neurooncol. 1999 Apr;42(2):109-16
references: 10421067
references: Breast Cancer Res Treat. 2000 Jan;59(1):69-76
references: 10752681
references: Lancet Oncol. 2009 Aug;10(8):751-2
references: 19655431
references: Acta Oncol. 2009;48(1):59-66
references: 18752084
references: Acta Neurochir Suppl. 1996;65:50-3
references: 8738495
references: Int J Cancer. 2010 May 15;126(10):2259-67
references: 19642094
references: Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):81-95
references: 14687599
references: J Natl Cancer Inst. 2003 Apr 2;95(7):526-32
references: 12671020
references: IARC Sci Publ. 1994;(128):1-302
references: 7698823
references: Cancer. 2002 Mar 15;94(6):1626-35
references: 11920521
references: Neurosurgery. 2009 Sep;65(3):483-9; discussion 489
references: 19687693
references: J Natl Cancer Inst. 2002 Oct 16;94(20):1555-63
references: 12381708
references: Br J Cancer. 2006 Jul 3;95(1):118-22
references: 16755290
references: IARC Sci Publ. 1987;(82):1-406
references: 3329634
references: Clin Cancer Res. 2000 Sep;6(9):3570-5
references: 10999746
references: Neurosurgery. 2007 May;60(5):787-98; discussion 787-98
references: 17460514
references: PLoS One. 2014 Feb 20;9(2):e88238
references: 24586311
references: Am J Epidemiol. 2012 Feb 15;175(4):309-14
references: 22287638
references: Int J Cancer. 2010 Oct 1;127(7):1692-8
references: 20091865
references: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70
references: 18843008
references: Drug Saf. 2004;27(13):979-89
references: 15471505
references: J Neurooncol. 1993 Jan;15(1):75-7
references: 8455065
references: Surg Neurol. 1985 Sep;24(3):245-9
references: 4023903
references: Cancer Res. 2008 Jan 1;68(1):314-22
references: 18172325
references: Neurosurg Focus. 2007;23(4):E2
references: 17961039
references: Cancer Causes Control. 2010 Dec;21(12):2149-56
references: 20730482
references: Int J Cancer. 2000 Jan 1;85(1):78-81
references: 10585587
references: Genes Chromosomes Cancer. 1997 Sep;20(1):53-9
references: 9290954
references: J Neurosurg. 1997 Jan;86(1):113-20
references: 8988089
references: Int J Cancer. 2006 Aug 15;119(4):909-14
references: 16557572
references: J Neurooncol. 2010 Sep;99(3):307-14
references: 20821343
references: Cancer. 2007 Aug 1;110(3):471-6
references: 17580362
references: Lancet. 1989 Jan 21;1(8630):117-20
references: 2563046
references: BMC Cancer. 2006 Jun 07;6:152
references: 16759391
references: Eur J Surg Oncol. 1998 Aug;24(4):332-4
references: 9725004
references: Eur J Cancer. 2009 Jul;45(11):1916-23
references: 19398327
references: Breast Cancer (Dove Med Press). 2014 Feb 17;6:29-36
references: 24648767
references: Int J Cancer. 1997 Jul 29;72(3):389-93
references: 9247278